65 related articles for article (PubMed ID: 24788664)
1. Prognostic value of PPM1D in 800 gastric cancer patients.
Ma D; Zhang CJ; Chen ZL; Yang H
Mol Med Rep; 2014 Jul; 10(1):191-4. PubMed ID: 24788664
[TBL] [Abstract][Full Text] [Related]
2. PPM1D as a novel biomarker for prostate cancer after radical prostatectomy.
Jiao L; Shen D; Liu G; Jia J; Geng J; Wang H; Sun Y
Anticancer Res; 2014 Jun; 34(6):2919-25. PubMed ID: 24922655
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of TMPRSS4 in gastric cancer.
Sheng H; Shen W; Zeng J; Xi L; Deng L
Neoplasma; 2014; 61(2):213-7. PubMed ID: 24299317
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of HOXA10 promotes gastric cancer cells proliferation and HOXA10(+)/CD44(+) is potential prognostic biomarker for gastric cancer.
Han Y; Lu S; Wen YG; Yu FD; Zhu XW; Qiu GQ; Tang HM; Peng ZH; Zhou CZ
Eur J Cell Biol; 2015 Dec; 94(12):642-52. PubMed ID: 26552644
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.
Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ
World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949
[TBL] [Abstract][Full Text] [Related]
6. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer.
Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ
World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value of CD44 expression in gastric cancer: a meta-analysis.
Chen Y; Fu Z; Xu S; Xu Y; Xu P
Biomed Pharmacother; 2014 Jul; 68(6):693-7. PubMed ID: 25194445
[TBL] [Abstract][Full Text] [Related]
8. The serine-threonine protein phosphatase PPM1D is frequently activated through amplification in aggressive primary breast tumours.
Rauta J; Alarmo EL; Kauraniemi P; Karhu R; Kuukasjärvi T; Kallioniemi A
Breast Cancer Res Treat; 2006 Feb; 95(3):257-63. PubMed ID: 16254685
[TBL] [Abstract][Full Text] [Related]
9. Serum neural precursor cell-expressed, developmentally down regulated 9 (NEDD9) level may have a prognostic role in patients with gastric cancer.
Karabulut M; Alis H; Afsar CU; Karabulut S; Kocatas A; Oguz H; Aykan NF
Biomed Pharmacother; 2015 Jul; 73():140-6. PubMed ID: 26211595
[TBL] [Abstract][Full Text] [Related]
10. Increased MT2-MMP expression in gastric cancer patients is associated with poor prognosis.
Xu X; Chen L; Xu B; Xie Q; Sun M; Deng X; Wu C; Jiang J
Int J Clin Exp Pathol; 2015; 8(2):1985-90. PubMed ID: 25973093
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic phosphatase Wip1 is a novel prognostic marker for lung adenocarcinoma patient survival.
Satoh N; Maniwa Y; Bermudez VP; Nishimura K; Nishio W; Yoshimura M; Okita Y; Ohbayashi C; Hurwitz J; Hayashi Y
Cancer Sci; 2011 May; 102(5):1101-6. PubMed ID: 21281403
[TBL] [Abstract][Full Text] [Related]
12. LAPTM4B-35, a cancer-related gene, is associated with poor prognosis in TNM stages I-III gastric cancer patients.
Cheng X; Zheng Z; Bu Z; Wu X; Zhang L; Xing X; Wang X; Hu Y; Du H; Li L; Li S; Zhou R; Wen XZ; Ji JF
PLoS One; 2015; 10(4):e0121559. PubMed ID: 25849595
[TBL] [Abstract][Full Text] [Related]
13. PPM1D is a prognostic marker and therapeutic target in colorectal cancer.
Peng TS; He YH; Nie T; Hu XD; Lu HY; Yi J; Shuai YF; Luo M
Exp Ther Med; 2014 Aug; 8(2):430-434. PubMed ID: 25009596
[TBL] [Abstract][Full Text] [Related]
14. Expression levels of insulin-like growth factor-1 and multidrug resistance-associated protein-1 indicate poor prognosis in patients with gastric cancer.
Ge J; Chen Z; Wu S; Chen J; Li X; Li J; Yin J; Chen Z
Digestion; 2009; 80(3):148-58. PubMed ID: 19713703
[TBL] [Abstract][Full Text] [Related]
15. Identification and validation of Kallikrein-ralated peptidase 11 as a novel prognostic marker of gastric cancer based on immunohistochemistry.
Wen YG; Wang Q; Zhou CZ; Yan DW; Qiu GQ; Yang C; Tang HM; Peng ZH
J Surg Oncol; 2011 Oct; 104(5):516-24. PubMed ID: 21618246
[TBL] [Abstract][Full Text] [Related]
16. Loss expression of PHLPP1 correlates with lymph node metastasis and exhibits a poor prognosis in patients with gastric cancer.
Wang Z; Shu H; Wang Z; Li G; Cui J; Wu H; Cai S; He W; He Y; Zhan W
J Surg Oncol; 2013 Dec; 108(7):427-32. PubMed ID: 24037758
[TBL] [Abstract][Full Text] [Related]
17. Clinical-pathological implication of human leukocyte antigen-F-positive gastric adenocarcinoma.
Ishigami S; Arigami T; Setoyama T; Okumura H; Sasaki K; Uchikado Y; Kurahara H; Kijima Y; Nishizono Y; Nakajo A; Natsugoe S
J Surg Res; 2013 Oct; 184(2):802-6. PubMed ID: 23706560
[TBL] [Abstract][Full Text] [Related]
18. Vimentin expression is associated with decreased survival in gastric cancer.
Otsuki S; Inokuchi M; Enjoji M; Ishikawa T; Takagi Y; Kato K; Yamada H; Kojima K; Sugihara K
Oncol Rep; 2011 May; 25(5):1235-42. PubMed ID: 21327330
[TBL] [Abstract][Full Text] [Related]
19. Caveolin 1 expression correlates with poor prognosis and focal adhesion kinase expression in gastric cancer.
Nam KH; Lee BL; Park JH; Kim J; Han N; Lee HE; Kim MA; Lee HS; Kim WH
Pathobiology; 2013; 80(2):87-94. PubMed ID: 23038627
[TBL] [Abstract][Full Text] [Related]
20. Low expression of DLC1 is predictive of poor therapeutic efficiency of fluoropyrimidine and oxaliplatin as adjuvant chemotherapy in gastric cancer.
Su Y; Lin L; Zhang J; Jiang Y; Pan C; Sun L; Duan J; Liao W
Mol Med Rep; 2015 Oct; 12(4):5771-9. PubMed ID: 26239822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
